Health IT Analytics July 13, 2022
The agency has partnered with AiCure to deploy artificial intelligence solutions as part of its PTSD Drug Treatment Program, which aims to optimize treatment and increase patient support.
The US Defense Health Agency (DHA) has announced that its PTSD Drug Treatment (PTSD-DT) Program will utilize New York-based artificial intelligence (AI) and data analytics company AiCure’s medication adherence and digital biomarker solutions to evaluate the efficacy of multiple PTSD treatments in service members and veterans.
Estimates of PTSD prevalence vary, but the US Department of Veterans Affairs’ National Center for PTSD reports that the National Comorbidity Survey Replication (NCS-R), conducted between February 2001 and April 2003, found that the lifetime prevalence of PTSD among adult Americans was 6.8 percent. Lifetime...
Today's Sponsors
Today's Sponsor